<DOC>
	<DOCNO>NCT00726505</DOCNO>
	<brief_summary>The purpose study evaluate effect dapagliflozin promote glucose loss urine healthy subject subject type 2 diabetes mellitus</brief_summary>
	<brief_title>Renal Mechanism Action/Splay vs. TmG</brief_title>
	<detailed_description />
	<criteria>Male female subject Age 18 65 year BMI 18 35 kg/m2 Healthy subject subject type 2 diabetes mellitus 1 follow therapy : diet , sulfonylurea , and/or metformin No evidence impair renal function Unwilling unable use acceptable method birth control Subjects type 1 diabetes mellitus , heart disease , hepatic C B Exposure insulin Use exclusionary concomitant medication Evidence significant kidney disease significant medical psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>